Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

500 East Philadelphia Avenue Operations LLC SHILLINGTON 19607

UEI: SLED_B64E9DA3FDF79975

500 East Philadelphia Avenue Operations LLC SHILLINGTON 19607 is a federal contractor, registered under UEI SLED_B64E9DA3FDF79975. It has been awarded $3,519,211 across 1 federal contract. Primary work spans Nursing Care Facilities (Skilled Nursing Facilities). Top awarding agencies include 244-NETWORK Contract Office 4 (36C244).

Contact Information

Registration and classification details

Registration

UEI Code

SLED_B64E9DA3FDF79975

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
244-NETWORK Contract Office 4 (36C244)$3.5M100%
Awards by NAICS
623110 - Nursing Care Facilities (Skilled Nursing Facilities)$3.5M100%
Awards by Agency Over Time
Export
Awards by Place of Performance

Open opportunities in 500 East Philadelphia Avenue Operations LLC SHILLINGTON 19607's top NAICS codes and agencies

NAICS: 621511
New
Federal
Q301--Lab Testing Services - clonoSEQ Measurable Residual Disease Test Pittsburgh VA Medical Center - Pittsburgh, PA
Solicitation # 36C24426Q0855
The Department of Veterans Affairs’ Network Contracting Office 4 intends to award a sole source contract to Adaptive Biotechnologies Corporation for the provision of clonoSEQ Measurable Residual Disease (MRD) testing services at the Pittsburgh VA Medical Center. This action is justified under FAR 6.103-1 because Adaptive Biotechnologies is the exclusive provider of the clonoSEQ assay, a proprietary, FDA-cleared, and CLIA-validated molecular test used to detect MRD in patients with multiple myeloma, B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other lymphoid malignancies. The contract will use simplified acquisition procedures, be firm fixed price, and span a five-year period with an annual quantity of 100 tests. The solicitation number is 36C24426Q0855, and the NAICS code is 621511 with a size standard of $41.5 million. Any interested party may submit a capability statement prior to the response deadline of August 10, 2026, at 8:00 AM Eastern Standard Time, but the Government retains full discretion to proceed without competition based on the unique nature of the technology and the absence of viable alternatives. Responses must include the company name, SAM UEI number, address, point of contact details, business size, and evidence demonstrating the ability to perform the service, including relevant experience, contract numbers, dollar amounts, performance periods, and customer contacts. All submissions must be emailed to Mickeya Linzie at mickeya.linzie@va.gov and must clearly state whether the respondent is the direct provider or an authorized reseller. No submissions will be accepted after the deadline, and all information provided becomes the property of the Government.
244-NETWORK Contract Office 4 (36C244)

POSTED

4 days ago

DEADLINE

in 6 days
View Details
NAICS: 621991
New
Federal
6506--Notice of Intent to Sole Source - Lab Supplies (Blood) Erie VA Medical Center - Erie, PA
Solicitation # 36C24426Q0612
The Department of Veterans Affairs, through the Network Contracting Office 4 in Pittsburgh, intends to award a sole source contract to the Community Blood Bank of Northwest Pennsylvania & Western New York for the supply of blood and blood components and specialized immunohematology reference laboratory services to the Erie VA Medical Center. The contract will be awarded under simplified acquisition procedures using firm pricing over a five-year period, with the sole justification being the vendor’s unique ability to deliver critical blood products within one hour of notification due to its proximity to the medical center. The required items include leukoreduced packed red blood cells, pathogen-reduced platelets, fresh frozen plasma, washed and re-washed red blood cells, and an annual immunohematology reference service, along with associated tariff surcharges and after-hours delivery fees. All responsible vendors are invited to submit written capability statements prior to the deadline of August 10, 2026, at 8:00 AM Eastern Time, demonstrating their ability to meet the requirement, including direct supplier confirmation, relevant contract history, performance details, and customer contacts. Responses must include the company name, SAM UEI number, address, point of contact information, and business size certification. The acquisition falls under NAICS code 621991 with a $40 million size standard, and submissions must be sent via email to the designated contracting officer. The government retains full discretion to proceed with sole source award regardless of any responses received, and no submissions will be accepted after the deadline.
244-NETWORK Contract Office 4 (36C244)

POSTED

4 days ago

DEADLINE

in 6 days
View Details